welcome and introduction, session 712
TRANSCRIPT
CONTEMPORARY DEBATES IN HEART FAILURE AND HYPERTENSION
Joint Symposium of the Association of Black Cardiologists, the American Society of Hypertension and the American College of Cardiology
• Advances in Heart Failure For African Americans:
Paradigm Shift or Paradigm Drift?
• 2014 Evidence-Based Guideline For the Management
of High Blood Pressure: Did They Get It Right?
AG
EN
DA
• Case Presentation with Key Clinical Pearls
• Panel Discussion with Audience Question and Answer
DEBATES
• 8442 patients with class II-IV heart failure with LVEF 40% or less
• LCZ696 vs enalapril in addition to standard therapy
• 20% reduction in death and hospitalization
• Small number of Blacks enrolled
Advances in Heart Failure
For African Americans:
Paradigm Shift or Paradigm Drift?
PRO
Clyde W. Yancy
• 1050 AA patients with dilated ventricles and NYHA class III-IV heart failure
• Fixed dose hydralazine and isosorbide vs placebo
• 43% reduction in mortality
• 33% reduction in first hospitalization
• Surprisingly low utilization despite guideline recommendation
Advances in Heart Failure
For African Americans:
Paradigm Shift or Paradigm Drift?
CON
Elizabeth Ofili
Advances in Heart Failure
For African Americans:
Paradigm Shift or Paradigm Drift?
PRO CON
YANCY versus
OFILI
• BP goal <150/90mHg in patients 60 years or older without
renal disease or diabetes
• Higher than previous recommendation of <140/90mmHg
2014 Evidence-Based Guideline
For the Management of High Blood
Pressure: Did They Get It Right?
PRO
Joel Handler
Raising the SBP goal to 150 mm Hg in persons who are 60
years of age – especially in African Americans – may have
a substantial negative impact on gains that have been
made in the last several decades in the treatment of CVD.
2014 Evidence-Based Guideline
For the Management of High Blood
Pressure: Did They Get It Right?
CON
William Elliott
2014 Evidence-Based Guideline For
the Management of High Blood
Pressure: Did They Get It Right?
PRO CON
HANDLER versus
ELLIOTT
Case Presentation with Key Clinical Pearls
Domenic A. Sica
Panel Discussion with Audience Question and Answer